LactobacillusBacteremia, Clinical Significance, and Patient Outcome, with Special Focus on ProbioticL. RhamnosusGG

Abstract

Lactobacillus bacteremia is a rare entity, and its clinical significance is poorly defined. We have reviewed the risk factors and outcome for 89 case patients with Lactobacillus bacteremia. Species characterization was done in 53% of the cases, revealing 25 L. rhamnosus strains and 22 other Lactobacillus species. In 11 cases, the strain was identical with the probiotic L. rhamnosus GG. In 82% of the cases, the patients had severe or fatal comorbidities. Predisposing factors to bacteremia were immunosuppression, prior prolonged hospitalization, and prior surgical interventions. No significant differences were observed in these predisposing factors or clinical features between patients with cases associated with the various Lactobacillus species, other than higher C-reactive protein values in patients with L. rhamnosus bacteremia. Mortality was 26% at 1 month and was 48% at 1 year. In multivariate analysis, severe underlying diseases were a significant predictor for mortality (odds ratio [OR], 15.8), whereas treatment with antimicrobials effective in vitro was associated with lower mortality (OR, 0.22). We conclude that lactobacilli in blood cultures are of clinical significance and that their susceptibility should guide decisions about antimicrobial treatment.

Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study

“…Patients who received Lactobacillus during chemotherapy reported less abdominal discomfort than those who did not receive it, and these subjects had also fewer chemotherapy-dose reductions, which might have an impact on chemotherapy efficacy. As many other bacteria, lactobacilli may occasionally cause septicaemia in severely immunocompromised patients (Salminen et al, 2004), but L. rhamnosus was identified in none of the blood cultures during the study. There was no difference between the allocation groups in the frequency of neutropenic fever.…”

Antibiotic susceptibility of Lactobacillus rhamnosus strains isolated from Parmigiano Reggiano cheese

“…Bacteriosis caused by lactobacilli is considered to be rare but risk factors related to Lactobacillus species include impaired host defences and severe underlying diseases, as well as prior surgery and prolonged antibiotic therapy ineffective for lactobacilli [36].…”

Lactobacilli for the Treatment of Oral Diseases

“…Most cases of probiotic bacteraemia responded well to appropriate antibiotic therapy. Common risk factors to Lactobacillus bacteraemia are immunosuppression, prior hospitalisation and previous antibiotic treatment [15]. Even in HIVinfected patients, the use of the probiotic L. rhamnosus GG was well tolerated and no adverse effects, like bacteraemic outbreaks, were observed [10].…”